IPSC vs LEN
Century Therapeutics Inc (IPSC) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
LEN (LEN) common stock.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
LEN does not have a complete income-statement cache yet.
IPSC currently screens at market cap $47.8M. LEN currently screens at market cap $0.
Not investment advice. Open the IPSC and LEN stock pages for the full models.
Not investment advice.